Service

Precise Diagnosis & Better Health

Who We Are？

XABT, Beijing Applied Biological Technologies Co., Ltd, a high-tech enterprise main focus on providing complete solutions for the detection of infectious pathogens in the medical and health field. With multiple PCR technology platforms, our team researched and develop more than 400 PCR detection reagents for CDC and hospital systems used; including SARS Covid-19, Food-borne & diarrhea, Respiratory disease, HFMD, Gastrointestinal infections, and other series. XABT continues to evolve and innovate its product lines and system for meeting the needs of the industry. For quality control, we built up a production workshop with ISO13485 quality system certified and meet new GMP standards which ensure product quality in the research and transportation process.

As a leading global provider of in-vitro diagnostics supplies since 2010, XABT is headquartered in Beijing and has more than 500 associates working with partners across the world, including Asia, Europe, America, and the Middle East.

Vision & Responsibility

To be a professional & top-tier IVD enterprise, our company has developed a series of top-quality molecular diagnostic reagents for Pathogen detection, infectious disease, and others.

2 Self-testing CE: CE certification for self-testing

34 Patents: 34 Patents and was awarded ‘The Patent Application Pilot of Beijing’ for the outstanding achievements in a patent application in 2015 as Pioneers of Multiple PCR Technology Application

150+ Distributors: With 150+ distributors & sales force worldwide

200+ CE: XABT obtained more than 200 CE certificates

2000+Cooperation Organization: 1,000+ Hospitals and 1000+ CDC cooperation

10 million+: up to 10 million satisfied customers

Why Choose us？

1. Hi-Tech Manufacturing Equipment

Our core manufacturing equipment is imported directly from Germany.

2. Strong R&D Strength

We have 15 engineers in our R&D centre, all of them are doctors or professors from University of Science and Technology of China.

3. Strict Quality Control

3.1 Core Raw Material.

Our ITO film (no shrinkage, no color difference) and liquid crystal spacer (excellent uniformity) are imported directly from Japan; glue is imported directly from Europe; our liquid crystal temperature range is 70°C and protective film is resist to high temperature 80-90°C.

3.2 Finished Products Testing.

High & low temperature test at 75°C and -35°C for 500 hours; thermal shock test 10°C-90°C for 30 minutes; damp heat test for 500 hours; moisture removed by oven; smart films in sheet are powered by a 24-hour aging test; smart films in roll are tested with 100V high voltage to make sure zero breakdown.

4. OEM & ODM Acceptable

Customized sizes and shapes are available. Welcome to share your idea with us, let’s work together to make life more creative.

Watch Us in Action!

Beijing Applied Biological Technologies Co., LTD. was established in 2010 and has been producing PCR Detection Kits for 11 years.

Technology, Production and Testing

The overall production base exceeds 9000 ㎡, including 100,000-level workshops, an automatic testing industrialization system, laboratories, 24 hours running cold chain warehouses, and offices. The 3 main manufacturing factories with 2 reagent research & development centers, and 1 instrument research & development center. The annual output exceeds 200 million copies, with more than 1,000 automatic machines.

Mainly focuses on precise one-step In-vitro Diagnostics solutions, providing colloidal gold, latex, fluorescence, or immunochromatography-related solutions, with a total value of tens of millions.

Multiple R&D technology platforms: PCR detection technology platform, immunochromatography technology platform, high-throughput sequencing technology platform.

Multiple production technologies: premix technology, freeze-drying powder technology, pre-loading technology, etc

Full range of products and service solutions: from sample pre-treatment, testing instruments, testing reagents, and analysis software, to technical support services.

In addition, XABT will continue to innovate and make breakthroughs on the following platforms in the future. flow cytometers, mass spectrometers, first-generation, second-generation, and third-generation sequencing instruments.

Development History

2020

XABT's newly developed “2019-nCov” PCR detection kit was approved by NMPA.
2019

Our influenza A/B and HFMD PCR kits were approved by NMPA（CFDA）and achieved “Medical Device Manufactures License”
2018

Our joint R&D project with CDC was awarded the third prize of Beijing science technology committee and the third prize of Chinese Medical Association; XABT was awarded “Changping R&D center”
2017

OXABT passed 13485 medical device quality system certification
2016

Our products passed the certification of CE and got business license of medical devices
2015

XABT was awarded “Gazelle Enterprise”
2013

XABT was awarded “National High Tech Company“
2012

XABT was awarded “High Tech Company” of Zhongguancun; XABT launched the first multiple PCR kit for detection of 5 types of Purgative Escherichia coli
2010

Foundation of XABT

Future

XABT is a growing global company, with subsidiaries in more than 10 countries and over 10 manufacturing collaborations around the world. Our long-term goal is to explore new markets and regions and bring the mission of precise diagnosis and better health worldwide.

OUR TEAM

With major marketing systems: public health marketing, clinical marketing, oversea marketing, ICL marketing, and OTC marketing. The overall team has 600+ employees, 60% involved in R&D, and the sales department specializes in research, development, and turnover. Cooperate with a number of scientific research colleges and universities to develop innovative products. In 2021, the company invested 51.02 million RMB in R&D, an increase of 67% compared to last year's investment.